Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
This comparison outlines 2024 tax treatment differences between dividends from ETFs and mutual funds for informed decisions.
24,763 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Balancer Labs will shut down after a $128 million exploit, pushing the protocol toward decentralized governance as th...
Anchorage Digital Bank announced a regulatory milestone, bringing Tron inside the U.S. regulatory perimeter. The move...
Exxon Mobil topped expectations in Q1 as LNG and Guyana projects accelerate. Investors are eyeing exxon mobil’s next ...
A federal court clears a $71 million ETH transfer on Arbitrum to Aave, but North Korea-linked creditors retain legal ...
Coinbase expands its collateral options by adding SOL to its crypto-backed loan program, unlocking new borrowing powe...
A bold alliance between Tether, Tron, and TRM Labs is expanding enforcement beyond borders. With 23 countries in its ...
Top foreign owners of U.S. debt are signaling a possible shift toward domestic allocations, a move that could squeeze...
A voluntary recall of thousands of Waymo AVs grabbed headlines, but the bigger story is the decade ahead for autonomo...
Mel Robbins, the millionaire podcaster, pushes back against the Gen Z lazy stereotype, arguing that today’s young wor...
Champion Homes announces a definitive agreement to acquire the majority of Homes Direct assets, expanding its 95-stor...
Kenya's High Court halted a U.S. plan to establish a quarantine facility for Americans exposed to Ebola, delaying a $...